Cargando…

BRAF‐V600E immunohistochemistry in a large series of glial and glial–neuronal tumors

INTRODUCTION: Some glial–neuronal tumors (GNT) (pleomorphic xantho‐astrocytoma [PXA], ganglioglioma [GG]) display BRAF‐V600E mutation, which represents a diagnostic clue to these entities. Targeted therapies against BRAF‐V600 protein have shown promising results in GNT. The aim of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Breton, Quentin, Plouhinec, Hélène, Prunier‐Mirebeau, Delphine, Boisselier, Blandine, Michalak, Sophie, Menei, Philippe, Rousseau, Audrey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346524/ https://www.ncbi.nlm.nih.gov/pubmed/28293477 http://dx.doi.org/10.1002/brb3.641

Ejemplares similares

RNA-sequencing of IDH-wild-type glioblastoma with chromothripsis identifies novel gene fusions with potential oncogenic properties
por: Ah-Pine, Franck, et al.
Publicado: (2020)

Application of optogenetic glial cells to neuron–glial communication
por: Hyung, Sujin, et al.
Publicado: (2023)

Validation of Immunohistochemistry for the Detection of BRAF V600E-Mutated Lung Adenocarcinomas
por: Gow, Chien-Hung, et al.
Publicado: (2019)

HGG-40. EXCEPTIONAL SYNCHRONOUS OCCURENCE OF A BRAF V600E MUTANT GLIOBLASTOMA AND A H3.3K27M MUTANT DIFFUSE INTRINSIC PONTINE GLIOMA: A CASE REPORT
por: De Carli, Emilie, et al.
Publicado: (2020)

Glial Tissue Mechanics and Mechanosensing by Glial Cells
por: Pogoda, Katarzyna, et al.
Publicado: (2018)

Immunohistochemistry is highly sensitive and specific for detection of BRAF V600E mutation in pleomorphic xanthoastrocytoma
por: Ida, Cristiane M, et al.
Publicado: (2013)

Clinical significance of immunohistochemistry to detect BRAF V600E mutant protein in thyroid tissues
por: Zhang, Yini, et al.
Publicado: (2021)

BRAF V600E Immunohistochemistry Predicts Prognosis of Patients with Cutaneous Melanoma in Thai population
por: Meevassana, Jiraroch, et al.
Publicado: (2022)

Utility of BRAF VE1 Immunohistochemistry as a Screening Tool for Colorectal Cancer Harboring BRAF V600E Mutation
por: Kwon, Jeong-Hwa, et al.
Publicado: (2018)

Whole genome duplication is an early event leading to aneuploidy in IDH-wild type glioblastoma
por: Boisselier, Blandine, et al.
Publicado: (2018)

Neuronal and glial cell biology
por: Brophy, Peter, et al.
Publicado: (2009)

Glial tauopathy: Neurons optional?
por: Walker, Lary C.
Publicado: (2019)

Comparison of Immunohistochemistry and Direct Sanger Sequencing for Detection of the BRAF(V600E) Mutation in Thyroid Neoplasm
por: Oh, Hye-Seon, et al.
Publicado: (2018)

Reflectance confocal microscopy features of BRAF V600E mutated thin melanomas detected by immunohistochemistry
por: Urvanegia, Ana Claudia, et al.
Publicado: (2017)

Glial Plasticity
por: Bellamy, Tomas C., et al.
Publicado: (2015)

Calcium in Neuronal and Glial Response to Axotomy
por: Khaitin, Andrey
Publicado: (2021)

VE1 immunohistochemistry predicts BRAF V600E mutation status and clinical outcome in colorectal cancer
por: Schafroth, Christian, et al.
Publicado: (2015)

Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients?
por: Schirosi, Laura, et al.
Publicado: (2016)

Immunohistochemistry cannot replace DNA analysis for evaluation of BRAF V600E mutations in papillary thyroid carcinoma
por: Szymonek, Monika, et al.
Publicado: (2017)

Immunohistochemistry as an accurate tool for the assessment of BRAF V600E and TP53 mutations in primary and metastatic melanoma
por: Rusu, Stefan, et al.
Publicado: (2021)

High frequency of BRAF V600E mutations in ameloblastoma
por: Kurppa, Kari J, et al.
Publicado: (2014)

Quantifying Glial-Glial Tiling Using Automated Image Analysis in Drosophila
por: Salazar, Gabriela, et al.
Publicado: (2022)

Clinical utility of serum glial fibrillary acidic protein in glial neoplasm
por: Yadav, Nidhi, et al.
Publicado: (2022)

Intracellular Neuroprotective Mechanisms in Neuron-Glial Networks Mediated by Glial Cell Line-Derived Neurotrophic Factor
por: Mitroshina, Еlena V., et al.
Publicado: (2019)

Building glial microtubules
por: LeBrasseur, Nicole
Publicado: (2005)

Glial phenotype modulators
por: Suk, Kyoungho
Publicado: (2017)

Glial cells in anorexia
por: Reyes-Haro, Daniel
Publicado: (2022)

Müller glial microRNAs are required for the maintenance of glial homeostasis and retinal architecture
por: Wohl, Stefanie G., et al.
Publicado: (2017)

NRAS(Q61R), BRAF(V600E) immunohistochemistry: a concomitant tool for mutation screening in melanomas
por: Uguen, Arnaud, et al.
Publicado: (2015)

VE1 Immunohistochemistry Improves the Limit of Genotyping for Detecting BRAF(V600E) Mutation in Papillary Thyroid Cancer
por: Choden, Sonam, et al.
Publicado: (2020)

VE1 immunohistochemistry is an adjunct tool for detection of BRAF (V600E) mutation: Validation in thyroid cancer patients
por: Rashid, Faiza A., et al.
Publicado: (2020)

Neuronal-glial networks as substrate for CNS integration
por: Verkhratsky, A, et al.
Publicado: (2006)

Distinctive Glial and Neuronal Interfacing on Nanocrystalline Diamond
por: Bendali, Amel, et al.
Publicado: (2014)

Editorial: Neuronal Pathways Affecting Glial Function
por: Buskila, Yossi, et al.
Publicado: (2021)

Rare Neuronal, Glial and Glioneuronal Tumours in Adults
por: Crainic, Nicolas, et al.
Publicado: (2023)

Can glial cells save neurons in epilepsy?
por: Shen, Weida, et al.
Publicado: (2022)

Prospective evaluation of two screening methods for molecular testing of metastatic melanoma: Diagnostic performance of BRAF V600E immunohistochemistry and of a NRAS-BRAF fully automated real-time PCR-based assay
por: Vallée, Audrey, et al.
Publicado: (2019)

Negative regulation of glial engulfment activity by Draper terminates glial responses to axon injury
por: Logan, Mary A., et al.
Publicado: (2012)

Activation of Glial FGFRs Is Essential in Glial Migration, Proliferation, and Survival and in Glia-Neuron Signaling during Olfactory System Development
por: Gibson, Nicholas J., et al.
Publicado: (2012)

SDPS-27 P16 IMMUNOHISTOCHEMISTRY AS A SCREENING TOOL FOR HOMOZYGOUS CDKN2A DELETIONS IN GLIAL TUMORS
por: Zschernack, Valentina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_diq6j386e1hmhj07ri057etpd0